Showing results (31-40 of 94) with videos related to
Sort By:
Pageof 10
JAMA Internal Medicine|February 7, 2018
Factors Associated With Variation in Long-term Acute Care Hospital vs Skilled Nursing Facility Use Among Hospitalized Older AdultsAnil N Makam, Oanh Kieu Nguyen, Lei Xuan, et al.BMC Health Services Research|November 12, 2020
Comparative effectiveness of long-term acute care hospital versus skilled nursing facility transferAnil N Makam, Oanh Kieu Nguyen, Michael E Miller, et al.Annals of the American Thoracic Society|June 15, 2016
Predicting the Risk of Readmission in Pneumonia. A Systematic Review of Model PerformanceMark Weinreich, Oanh K Nguyen, David Wang, et al.JAMA Network Open|May 28, 2024
Survival, Function, and Cognition After Hospitalization in Long-Term Acute Care HospitalsSnigdha Jain, Siqi Gan, Oanh K Nguyen, et al.Circulation. Cardiovascular Quality and Outcomes|January 12, 2018
Acute Myocardial Infarction Readmission Risk Prediction Models: A Systematic Review of Model PerformanceLauren N Smith, Anil N Makam, Douglas Darden, et al.Journal of General Internal Medicine|September 14, 2021
National Prevalence of Alcohol and Other Substance Use Disorders Among Emergency Department Visits and Hospitalizations: NHAMCS 2014-2018Leslie W Suen, Anil N Makam, Hannah R Snyder, et al.Journal of the American Geriatrics Society|October 20, 2021
Establishing Medicaid incentives for liberating nursing home patients from ventilatorsLaura M Keohane, Matthew F Mart, E Wesley Ely, et al.Journal of Hospital Medicine|March 2, 2016
Predicting all-cause readmissions using electronic health record data from the entire hospitalization: Model development and comparisonOanh Kieu Nguyen, Anil N Makam, Christopher Clark, et al.Journal of General Internal Medicine|August 10, 2016
Vital Signs Are Still Vital: Instability on Discharge and the Risk of Post-Discharge Adverse OutcomesOanh Kieu Nguyen, Anil N Makam, Christopher Clark, et al.Journal of Managed Care & Specialty Pharmacy|January 27, 2023
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory CouncilDmitriy Nikitin, Anil N Makam, Kangho Suh, et al.Pageof 10